Erlotinib in Treating Patients With Barrett Esophagus

Summary

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. Erlotinib may keep esophageal cancer from forming in patients with Barrett esophagus by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well erlotinib works in treating patients with Barrett esophagus.

Timeline

Start

2007-07

Primary completion

—

Completion

—

Drugs

Indications